3 Corresponding author mice homozygous for null alleles of certain cell typespecific transcription factors (Jonsson et al., 1994 ; Lin Expression of thyroglobulin (Tg) and thyroperoxidase et al., 1994; Kimura et al., 1996) show a complete (TPO) genes in thyroid follicular cells occurs in the subversion or even absence of the differentiated tissue. mouse at embryonic day (E)14.5. Two transcription Probably related to this observation is the fact that some factors, TTF-1 and Pax-8, have been implicated in cell type-specific transcription factors appear in developtranscriptional activation of Tg and TPO, even though ment long before expression of the target genes (Plachov the onset of their expression is at E9.5, suggesting Lazzaro et al., 1991; Poleev et al., 1992 ; additional events are necessary for transcriptional Lamonerie et al., 1996) , suggesting that they may play an activation of Tg and TPO genes. We report in this additional role(s) during organogenesis. paper the cloning of TTF-2, a DNA binding protein
We have been using specific expression of the thyrothat recognizes sites on both Tg and TPO promoters.
globulin (Tg) and thyroperoxidase (TPO) genes in follicu-TTF-2 is a new forkhead domain-containing protein lar cells of the thyroid gland as an experimental system whose expression is restricted to the endodermal lining to investigate the genetic mechanisms responsible for of the foregut and to the ectoderm that will give differentiation in vertebrates. By DNA binding assay, rise to the anterior pituitary. TTF-2 shows transient carried out on the functionally relevant regions of Tg and expression in the developing thyroid and anterior TPO promoters, three factors were identified: TTF-1, pituitary. In the thyroid, TTF-2 expression is down-TTF-2 and Pax-8. The cloning of TTF-1 (Guazzi et al. , regulated just before the onset of Tg and TPO geneIntroduction follicular cells in the rat and in mouse provided evidence that both TTF-1 and Pax-8 are present in the thyroid The genetic mechanisms responsible for differentiation in primordium at embryonic day (E)9.5, while expression of multicellular organisms ultimately converge upon the the known target genes Tg and TPO begins only at around transcriptional regulation of genes that are expressed E14. These observations suggest that between E13 and exclusively in a specific cell type. Several transcription E15 important events must occur that trigger the action factors have been identified that bind to and activate of TTF-1 and Pax-8 on the promoters of Tg, TPO and, transcription from promoters of cell type-specific genes presumably, other thyroid-specific genes. (Mitchell and Tjian, 1989; Simmons et al., 1990; In this paper we describe the cloning of TTF-2 cDNA Simone and Cortese, 1991; Damante and Di Lauro, 1994) . from a rat thyroid cDNA library. To date, TTF-2 has been Interestingly, most of the transcription factors thus identiidentified as a thyroid-specific DNA binding factor whose fied have been detected not only in cells that express the activity is sensitive to insulin, IGF-1 and thyroid stimulatgenes that they were originally discovered to activate ing hormone ; Aza-Blanc et al., but also in a few other cell types that display distinct 1993). The functional relevance of the interaction between differentiation programs. The emerging picture is that each TTF-2 and the Tg or the TPO promoters has been implied cell type contains a specific combination of transcription by the effect of mutations in the TTF-2 binding site of factors and that cooperation among them (Herschlag and each promoter (Sinclair et al., 1990; Francis-Lang et al., Johnson, 1993; Holloway et al., 1995, and references therein) or with non-DNA binding cofactors (Luo et al., 1992) . We show in this paper that TTF-2 is a new member of the family of proteins characterized by the presence of a forkhead domain. TTF-2 mRNA shows a very restricted tissue distribution, being transiently expressed only in the thyroid and in the embryonal anterior pituitary. In thyroid, TTF-2 mRNA, first detected at E9, disappears between E13 and E15. The precise correlation between TTF-2 down-regulation and the triggering of thyroid differentiation suggests that TTF-2 might function as a negative regulator of differentiation in the early stages of thyroid morphogenesis. In keeping with such a model, we demonstrate that TTF-2 represses transcriptional activation by both TTF-1 and Pax-8.
Results
Cloning of a cDNA encoding a new forkhead domain-containing protein The DNA sequence recognized by TTF-2 is similar to that recognized by transcription factors containing a forkhead domain (Sato and Di Lauro, 1996) . Hence, a rat thyroid library was screened with a DNA fragment derived from plasmid pCMV3β (kindly provided by Dr R.H.Costa) corresponding to the region encoding the forkhead domain of the transcription factor HNF3β. Partial sequencing of the 12 positive clones isolated revealed that they all encoded the same novel protein (data not shown). One of the clones ( Figure 1A , cl13), containing an insert~2500 bp long, included all the others and was completely sequenced, revealing an open reading frame (ORF) 1347 nt long that was followed by a 3Ј-untranslated region (UTR) a probe to screen a rat genomic library and to isolate a Riboprobes 2 and 3 protect a fragment of identical size (~490 bp), genomic clone (data not shown), from which a 1.9 kb longer than that protected by riboprobe 1. The resulting 5Ј-UTR is fragment, positive to the screening probe was subcloned indicated in the scheme.
in Bluescript ( Figure 1A , cl3.2) and completely sequenced. The nucleotide sequence of clone cl3.2 overlapped extensively with cl13 and extended for 970 bp upstream. RNase revealed the absence of introns in the corresponding genomic region (data not shown). mapping experiments were then performed to determine the extent of transcribed sequences present in cl3.2 ( Figure  The cDNA sequence in Figure 2A shows a long 5Ј-UTR, containing an ATG codon at position 212, surrounded by 1B). The three riboprobes used had a common 5Ј-end, located in a region overlapping with cDNA clone cl13, a good Kozak consensus sequence and followed by an inframe stop codon at position 248. After the stop codon, a and extended for various lengths into the genomic clone. Riboprobe 1 was completely protected by thyroid RNA, long ORF begins which encodes, between its first ATG codon at position 593 and the stop codon at nt 1702, a while riboprobes 2 and 3 were partially protected, yielding fragments of identical size. This experiment demonstrates 370 amino acid protein with a predicted relative molecular mass of 42 kDa. To establish the size of the protein that the mRNA from which cl13 is derived must extend into the sequence of clone cl3.2, in a region between the encoded, the sequence contained between nt 1 and 1705 of Figure 1 was amplified from a full-size genomic 3Ј-ends of riboprobes 2 and 3 ( Figure 1B ), whose precise location could be deduced by the size of the protected clone and subcloned in Bluescript (construct IVT 1 of Figure 2B ). Three mutants of IVT 1 were constructed fragments. This information was used to build the structure of a putative mRNA obtained by fusing the sequence of ( Figure 2B ): IVT 2 is identical to IVT 1 except that the first ATG is mutated to GTG; in IVT 3 the first ATG is clone cl13 and 355 nt from cl3.2. These conclusions were supported by RT-PCR experiments showing that when deleted, together with all the sequences upstream of the second ATG; this ATG is mutated to GTG in IVT 4, thyroid cDNA was used as a template it was possible to amplify the sequences downstream of the putative which is otherwise identical to IVT 3. mRNAs were transcribed from all four constructs, translated in an transcription start site identified by RNase mapping, while there was no amplification if one of the primers was in vitro reticulocyte lysate system in the presence of [ 35 S]methionine and the resulting products visualized by derived from the sequence upstream of it (data not shown). The composite sequence of Figure 2A has also been autoradiography ( Figure 2B ). mRNAs obtained from IVT 1, 2 and 3 all directed synthesis of a protein of 42 kDa confirmed by sequencing of genomic clones, which further relative molecular mass, which is consistent with initiation at the ATG in position 593. This indication was confirmed by the specific sensitivity of only the second ATG to mutagenesis, as indicated by the disappearance of the 42 kDa protein with the mRNA transcribed from the IVT 4 template. In this case, a new, smaller protein is obtained, probably initiating at a spurious downstream initiation site.
The most notable feature of the predicted protein is a 3Ј-UTR (underlined in Figure 2A ) which are alternatively hybridized with a TTF-2 specific probe. Two transcript of 2.8 and 2.3 kb were detected only in thyroid. In, intestine; Mu, muscle;
used to produce two differently sized mRNAs ( Figure 4 ).
Br, brain; He, heart; Li, liver; Lu, lung; Thy, thyroid. GADPH hybridization was used to normalize the amounts of RNA present in
The cloned cDNA encodes a protein that displays The full-length cDNA was subcloned in an expression re-addition of insulin to cells that had been previously starved (lane 3) vector under the control of a CMV promoter and the were hybridized to the same probe as in (A). 28S hybridization was construct thus generated (CMV·TTF-2) was transiently used to normalize the amounts of RNA present in the blots.
transfected into HeLa cells. Extracts prepared from transfected cells contained a DNA binding activity capable, in a band shift assay, of forming a complex with oligonucleo-(0/93) were found between titf2 and the previously scored Xpa (xeroderma pigmentosum complementation group A) tide K ( Figure 3A , left panel), derived from the TTF-2 binding site in the Tg promoter (Sinclair et al., 1990) .
locus on chromosome 4 (Chidambaram and Dean, 1996). The 95% upper confidence limit of the titf2-Xpa map The complex was competed for by a molar excess of unlabeled oligonucleotides containing the TTF-2 binding distance is 3.2 cM. titf2 mapped 9.6 Ϯ 3.0 cM distal to D4Mit4 and 8.5 cM proximal to Orm1 (orosomucoid-1). site from the Tg (K) or TPO (Z) promoters and it was not observed with extracts prepared These loci have been placed at positions 10.5 and 30.6 cM from the centromere in the mouse chromosome 4 map from mock-transfected HeLa cells ( Figure 3A , left panel). Furthermore, a complex of similar mobility was obtained (Mock et al., 1996) . The present data suggest that titf2 is located~22 cM from the centromere. The Xpa locus has with extracts derived from the thyroid cell line FRTL-5 ( Figure 3A , right panel).
been assigned to cytogenetic band 4C2 (Tanaka et al., 1990) , while the human homolog of Xpa maps to 9q22.3, To further investigate the binding properties of the protein encoded by the cDNA that we have cloned, a suggesting that titf2 and its human homolog will also map to the same regions. No mouse mutations affecting thyroid DNase I footprinting analysis was performed on the Tg and TPO promoters. As shown in Figure 3B , footprints function have been mapped to the region of chromosome 4 containing titf2. obtained with an FRTL-5 nuclear extract were compared with that obtained with extracts of HeLa cells transfected with either an empty expression vector (HeLa lanes in TTF-2 is expressed in adult thyroid and shows a tight hormonal control in cultured thyroid cells Figure 3B ) or with CMV·TTF-2 (TTF-2 lanes in Figure  3B) . In the Tg promoter the region specifically protected
To examine the tissue distribution of TTF-2 mRNA, total RNA was prepared from various adult rat tissues and by the protein expressed in transfected HeLa cells coincided with the footprint obtained with the FRTL-5 analyzed by Northern blot hybridization using a 0.35 kb probe derived from the 3Ј non-coding region. TTF-2 extract previously described as being TTF-2 (region K, Figure 3B ). The same results were obtained in the TPO showed a remarkable tissue-specific expression ( Figure  4A ), being present, among the tissues examined, only in promoter (region Z, Figure 3B ).
These data strongly indicate that the cDNA cloned has the thyroid. Two mRNAs, of 2.8 and 2.3 kb, were observed; Northern blots with specific oligonucleotides and sequencthe same binding properties as previously described for TTF-2.
ing of the 3Ј-UTR of several cDNA clones (data not shown) showed that the two transcripts originate by alternative use of the two polyadenylation signals identified Chromosomal localization of the TTF-2 gene High stringency hybridization of the labeled TTF-2 clone in the 3Ј-UTR of the longest cDNA (see Figure 2A ). TTF-2 binding activity is under strict insulin/IGF-1 to Southern blots of C57BL/6J and SPRET/Ei DNA digested with BamHI, BglII, EcoRI, EcoRV, HindIII, PstI, control, as it becomes undetectable in nuclear extracts from cells starved for insulin and can be induced upon NsiI, SstI and MspI revealed a distinct variant only with SstI, suggesting that this variant reflects a small DNA re-addition of insulin/IGF-1 in a dose-dependent manner . We thus chose regulation by sequence change rather than a large insertion/deletion mutation (data not shown). The C57BL/6J and SPRET/Ei insulin as an additional criterion to demonstrate that the cDNA that we isolated was indeed TTF-2. FRTL-5 cells SstI fragments were 4.3 and 5.1 kb respectively. Ninety four BSS interspecific backcross progeny (Rowe et al., were grown in medium depleted of insulin for 4 days and total RNA was prepared. Northern blot analysis showed 1994) were scored with respect to the presence or absence of the 4.3 kb TTF-2 SstI fragment from C57BL/6J. The that expression of our cDNA clone was strictly regulated by insulin, being detectable only in cells grown in regular locus thus identified is designated titf2. No recombinants medium or upon re-addition of insulin to cells that had TTF-2 expression inversely correlates with differentiation of thyroid follicular cells been previously starved ( Figure 4B) .
A critical event must occur in thyroid differentiation around E13 and E14, since most of the differentiation TTF-2 expression during embryonic development A 350 bp fragment derived from the 3Ј-UTR was used program is only activated at E14, even though the known regulators of thyroid-specific gene expression, including, as the probe to study TTF-2 expression during mouse development between E7.5 and E17, performing in situ as demonstrated by this study, TTF-2, are already expressed at E13 (Damante and Di Lauro, 1994) . Interesthybridizations on embryo sections. Control experiments using as a probe the sense strand of the same fragment ingly, at E15, when thyroid cells undergo differentiation, as shown by expression of thyroglobulin ( Figure 8F ), showed no detectable signals (data not shown). The first detectable signal was found at E8.5 in the endoderm TTF-2 transcripts became undetectable ( Figure 8D ), while TTF-1 expression remained high. These data suggest that corresponding to the floor of the foregut ( Figure 5A ). At E9.2-9.5 TTF-2 was expressed in the epithelium lining TTF-2 could function as an inhibitor of differentiation in the early stages of thyroid development, perhaps by the anterior foregut and the posterior stomodeum, including the pharyngeal membrane ( Figure 5B ). At E10.5 TTF-2 interfering with transcriptional activation of thyroidspecific gene expression by TTF-1 and, possibly, Pax-8. was transcribed along all the endoderm of the foregut lining the visceral pouch of the branchial arches ( Figure  5C, D and F) . Rostrally in the stomodeum TTF-2 expres-TTF-2 interferes with transcriptional activation by TTF-1 and Pax-8 sion was confined to the dorsal ectoderm ( Figure 5C -E and G). However, TTF-2 mRNA appeared undetectable
To test whether TTF-2 is indeed capable of interfering with transcriptional activation mediated by either TTF-1 in the most rostral ectoderm which lines the nasal process and the olfactory placode ( Figure 5C , D and G). TTF-2 or Pax-8 we used a co-transfection assay in HeLa cells.
We have previously shown that in these cells the Tg expression was evident in two endocrine gland primordia: Rathke's pouch, of ectodermal origin, that will form the promoter is best activated by TTF-1, while Pax-8 preferentially activates TPO transcription. Hence, the inhibitory anterior pituitary, and the thyroid anlage, a small group of endodermal cells that will form the thyroid follicular effect of TTF-2 was tested on either TTF-1-mediated Tg transcription or on Pax-8 activation of TPO. We also cell population ( Figure 5D and E) .
A more detailed analysis of TTF-2 expression in thyroid tested whether TTF-2 was able to repress TTF-1-dependent transcription on C5-E1b, an artificial promoter that conprecursors was performed, comparing it with expression of TTF-1, which is known to begin in thyroid cell tains multiple binding sites for TTF-1 in front of the E1b TATA box (De Felice et al., 1995) . As shown in Figure 9 , precursors at E8.5. At E8.5 TTF-1 was expressed in a small group of cells in the deep midline of the floor of both TTF-1-and Pax-8-mediated transcriptional activation, on the Tg or TPO promoters respectively ( Figure 9A and the foregut ( Figure 6A ). At that time TTF-2 was expressed through the foregut endoderm (see above) even though its C, black bars), were strongly interfered with by TTF-2 ( Figure 9A and C, hatched bars). Surprisingly, we observed expression did not peak in the thyroid early primordium ( Figure 6F ), but appeared much more evidently in posterior TTF-2-mediated transcriptional repression also on Tg and TPO promoter mutants ( Figure 9B and D) in which sections ( Figure 6G ) where TTF-1 was not transcribed ( Figure 6B ). At E9.5, both TTF-1 and TTF-2 transcripts the TTF-2 binding site was abolished by several base substitutions, suggesting that TTF-2 does not need to bind were detectable in the migrating thyroid primordium (compare Figure 6C with H) and during the following 3 DNA in order to repress transcription. Nonetheless, two lines of evidence suggest that TTF-2-mediated repression days (E10.5 and E12.5 in Figure 6 ) expression in the migrating thyroid cell precursors was very clearly detected is promoter specific: first, the CMV promoter used in our transfections as an internal control to normalize for ( Figure 6D , E, I and J). Hence, TTF-1 and TTF-2 appear to be co-expressed in the same cells in a defined temporal transfection efficiency was not affected by TTF-2 (data not shown) and, second, C5E1b, whose transcription is window during early thyroid development.
Expression of TTF-2 in the developing pituitary was completely dependent on TTF-1, was unaffected by TTF-2 ( Figure 9E ). To be certain about the promoter selectivity already evident in those ectodermal cells fated to develop into adenohypophysis that are located in close proximity of TTF-2 repression, C5E1b-CAT and Tg-Luc were transfected together, with or without TTF-1 and TTF-2 to the pharyngeal membrane in the inner stomodeum ( Figure 7F and FЈ) . It is likely that these cells, which are ( Figure 9F ). In this experiment Tg and C5E1b were activated by TTF-1 simultaneously, within the same cells; in direct apposition to the diencephalic floor, play an important role in inducing the neurohypophysis, which co-expression of TTF-2 only repressed Tg, leaving C5E1b unaffected, thus demonstrating the ability of TTF-2 to has been highlighted by hybridization of adjacent sections with TTF-1, a marker of developing neurohypophysis discriminate even among promoters activated by the same transcription factor. (Figure 7A-E) . Later, at E10.5-11.5, TTF-2 expression accompanied the migrating Rathke's pouch ( Figure 7G-I) , which moves upward to meet the descending infundibulum
Discussion
( Figure 7B-D) . By E12-12.5 Rathke's pouch was not connected with the oral cavity and showed a remarkable TTF-2 was identified as a thyroid-specific DNA binding protein able to recognize one binding site on the promoters proliferative activity. At this stage TTF-2 mRNA was undetectable in the adenohypophysis precursor cells of thyroglobulin (Civitareale et al., 1989) and thyroperoxidase , two genes ( Figure 7J ), while there were still high levels of TTF-1 mRNA in the infundibulum ( Figure 7E ). exclusively expressed in the thyroid . The similarity of the -G) . Bright fields of the same sections are indicated by a prime. nf, neural fold; fg, foregut; en, endoderm; he, heart; op, olfactory placode; phm, pharyngeal membrane; st, stomatoodeum; Di, diencephalon; in, infundibular diverticulum; Rp, Rathke's pouch; mg, midgut; I, II and III, the first, second and third branchial arches respectively; thp, thyroid primordium; ph, pharynx.
TTF-2 binding site to the consensus sequence recognized thyroid cDNA library. Using this approach, we isolated a cDNA encoding a new forkhead protein that we by proteins containing a forkhead domain prompted us to isolate cDNA clones encoding forkhead proteins from a demonstrate in this study to be TTF-2, on the basis of necessary for thyroid differentiation (Damante and Di Lauro, 1994 (Kimura et al., 1996) . Interestingly, both TTF-1 and Pax-8 proteins are present in the thyroid anlage stage at E8.5, suggesting that an additional, essential event(s) must occur to trigger differentiation of thyroid cells at E13-14 (Lazzaro et al., 1991) . We show in this paper that TTF-2 expression is turned off exactly between E13 and E15 in the developing thyroid. The correlation between the onset of thyroglobulin and thyroperoxidase gene expression and the disappearance of TTF-2 mRNA suggests that in the embryo the role of TTF-2 is to block activation of thyroid-specific gene expression by TTF-1 and Pax-8. We propose that thyroid cell precursors enter into a determined state at E8.5 which is characterized, and possibly induced, by the presence of TTF-1 and Pax-8. During the next 5 days, thyroid cell precursors undergo a long migration, at the end of which they will express their full differentiated phenotype. The presence of TTF-2 in the migrating thyroid cell precursors would prevent precocious expression of genes that might have an adverse effect on migration, for example because of changes in the adhesive properties of the cells.
In keeping with such a model, we show that TTF-2 is capable of interfering with transcriptional activation by TTF-1 and Pax-8 of Tg and TPO promoters respectively. TTF-2-mediated repression is binding site independent, as demonstrated by the sensitivity to TTF-2 repression of Tg and TPO promoters mutated in the TTF-2 binding sites. Repression of transcription in the absence of a cognate binding site has also been demonstrated for other DNA binding proteins and it is thought to be mediated by protein-protein interactions resulting in interference with assembly of the transcription machinery (Briata et al., 1995; Catron et al., 1995) . To exclude a non-specific effect of TTF-2, we determined its effects on other promoters. We observed no repression of the CMV promoter, used in all our transfections as an internal control (data not shown). TTF-2 repression was also tested on C5E1b, an artificial promoter containing five TTF-1 binding sites in front of the E1b TATA box. The C5E1b promoter, similarly to that of Tg, shows a strict dependence on TTF-1 for transcription in HeLa cells. Nevertheless, with TTF-1 but recognizes either a specific promoter architecture or components of the basal transcriptional apparatus that could be different between Tg and C5E1b, its binding properties, tissue distribution and hormonal regulation.
thus also providing a mechanism for interference by TTF-2 with only a subset of the genes activated by TTF-1. This Of particular interest is expression of TTF-2 during thyroid development. Thyroid follicular cells originate by observation is of relevance: the absence of a thyroid in TTF-1 knock-out mice (Kimura et al., 1996) suggests that invagination of pharyngeal endoderm beginning at E8-8.5 of mouse development (Ericson and Frederiksson, this factor is involved in morphogenesis and only later on takes up the function of activating transcription of 1990). The thyroid primordium migrates downward to reach its final destination in front of the trachea at E13-'terminally differentiated' genes. The discrimination operated by TTF-2 on TTF-1-dependent promoters could be 14. It is only at E15, after completion of the migration process, that thyroid follicular cells differentiate, as instrumental in repressing differentiation without interfering with morphogenesis. measured by expression of several thyroid-specific genes (Tg, TPO and TSHR) (Lazzaro et al., 1991) . Two transcripIn adult thyroid tissue TTF-2 expression is restored. Two, albeit indirect, lines of evidence suggest that in the tion factors, TTF-1 and Pax-8, have been proposed as adult thyroid TTF-2 functions as a transcriptional activator:
of TTF-2 as a transcriptional activator is lacking, it is tempting to speculate that TTF-2 biphasic expression is first, mutation in the TTF-2 binding site, in both the Tg and TPO promoters, results in reduced transcription required to switch from repression to activation of thyroidspecific gene expression. Possibly related to this latter (Sinclair et al., 1990; and, second, artificial promoters obtained by polymerizing function is binding of TTF-2 to DNA through a highly conserved 110 amino acid domain, the forkhead domain, the TTF-2 binding site are transcriptionally active and, furthermore, show hormonal regulation (Aza-Blanc et al., whose structure, known as the winged helix motif, has also been found in histone H5 (Clark et al., 1993 (Clark et al., ). 1993 . Even though direct evidence supporting the role The forkhead domain characterizes a large family of of TTF-2 in the developing pituitary resembles that of Rpx, a homeodomain-containing protein, whose expression is transcriptional regulators, also known as fkh (Kaestner et al., 1993) , HFH (Clevidence et al., 1993) or FREAC detected at E7, before the onset of TTF-2 expression. Rpx expression overlaps spatially and temporally with that of (Pierrou et al., 1994) . Similarly to other forkhead domaincontaining proteins (Pierrou et al., 1994) , TTF-2 is capable TTF-2 and is extinguished 1 day later, at E13.5 (Hermesz et al., 1996) . The onset of TTF-2 expression in the of bending DNA (data not shown). Other transcriptional regulators have been shown to exert their transcriptional developing pituitary just precedes that of α-GSU. Moreover, extinction of TTF-2 expression correlates with the effects via local modification of DNA bending (Falvo et al., 1995; Giese et al., 1995, and references therein;  onset of POMC expression, which occurs at E12 in the ventral part of the pituitary primordium (Elkabes et al., Thanos and Maniatis, 1995) . Such effects could be mediated by an influence on nucleosome positioning in a 1989). Interestingly, a homeodomain-containing transcription factor, Ptx1, that is capable of activating the POMC manner similar to HNF3, another member of the forkhead family that has been demonstrated to be essential for promoter begins to be expressed at E10.5 in Rathke's pouch (Lamonerie et al., 1996) . By analogy with the assembly of a multiprotein complex that actively directs nucleosome positioning within the albumin enhancer model discussed above on the role of TTF-2 in thyroid development, TTF-2 could prevent Ptx1 activation of the (McPherson et al., 1993 . In all the cases mentioned, alteration of local DNA or chromatin structure seems to POMC promoter. Such a model, which would explain the delay between the onset of Ptx1 expression and activation be required for transcriptional activation and could be used by TTF-2 to mediate its putative activating role in of POMC transcription, could be tested by assaying the effect of TTF-2 on transactivation of the POMC promoter adult thyroid cells.
Two other forkhead proteins, HNF3-α and HNF3-β, are by Ptx1. We show in this paper that in the differentiated thyroid expressed in the developing thyroid. Interestingly, both factors show a transient expression pattern, beginning at cell line FRTL-5 TTF-2 is under tight control by insulin and IGF-1 at the mRNA level. It is worth noting that E10.5 and terminating at E12.5 and E13.5 for HNF3-α and HNF3-β respectively (Monaghan et al., 1993) . We thyroid-specific expression of TTF-2 coincides in time with embryonic production of IGF-1 (Murphy et al., 1987 ; have recently shown that, similarly to TTF-2, HNF3-β expression is restored in adult thyroid gland and it is Rotwein et al., 1987) , suggesting a role for IGF-1 in expression of TTF-2 during development. detected in the FRTL-5 cell line (Bohinski et al., 1994) . Even though HNF3-β can recognize only the TTF-2 TTF-2 is expressed in two glands, the thyroid and the pituitary, which are part of a regulatory circuit responsible binding site on the TPO promoter and not that in the Tg promoter (Bohinski et al., 1994) , its temporal expression for homeostatic control of thyroid hormone production. The hypothalamus is also part of this circuit, where TTF-1, pattern in the thyroid is similar to that of TTF-2 and, hence, is consistent with a similar, perhaps redundant, role.
another transcription factor of relevance in thyroid cell function and differentiation, is expressed. In this respect, The overall expression pattern of the forkhead proteins HNF3-α, HNF3-β and HNF3-γ in the endoderm of the it is noteworthy that in TTF-1 knock-out mice the anterior pituitary, where TTF-1 is not expressed, is absent, perhaps gastrointestinal tract shows an interesting temporal and spatial, partially overlapping pattern, with HNF3-α and as a consequence of the absence of hypothalamic structures that are necessary to induce morphogenesis of the adeno-HNF3-β extending most anteriorly in the endoderm lining the oral cavity (Monaghan et al., 1993) . HNF3-β expreshypophysis (Kimura et al., 1996) . It is inviting to think that recruitment of the same regulatory molecules in sion extends further into ectodermally derived cells in the stomatodaeum and TTF-2 extends even further into different but functionally related organs in the thyroidpituitary-hypothalamic axis is advantageous to their coordRathke's pouch. Posteriorly, TTF-2 overlaps with the expression domain of HNF3-α and HNF3-β along all the inate development and function. endoderm of the foregut lining the visceral pouch of the branchial arches. In the lung and in all the posterior part
Materials and methods
of the gut, TTF-2 is absent. Thus it seems that different complements of forkhead proteins and their specific Library screening cooperation with other transcription factors could be an Samples of 8ϫ10 5 plaques of a rat thyroid cDNA library in λgt11 were plated and duplicate filter lifts were carried out according to standard important factor in regionalization and differentiation procedures. Pre-hybridization was carried out at 58°C for 2 h in 6ϫ along the foregut axis (Bohinski et al., 1994; Hellqvist SSC, 5ϫ Denhardt's, 0.2% SDS, 50 μg/ml salmon sperm DNA, et al., 1996) . that reciprocal inductive interactions occur between the hypothalamic and pituitary primordia and, hence, it is Plasmids Specific primers were used to amplify the entire coding region or deletion conceivable that TTF-2 gene expression in Rathke's pouch fragments of TTF-2 by PCR. EcoRI and MluI sites (5Ј-end and 3Ј-end cells is induced by signals originating in the developing respectively) were included in these primers to facilitate cloning. The neurohypophysis. By E12-12.5, when formation of amplified products were subcloned into the eukaryotic expression vector Rathke's pouch is completed, TTF-2 is undetectable in pCMV5. Alternatively, the PCR products were filled in with Klenow and cloned into the EcoRV site of the Bluescript KS vector. adenohypophysis precursor cells. The transient expression Specific methionine codons were changed to alanine codons by PCR probe in hybridization mix was added to each slide. Hybridization was carried out overnight at 55°C. The slides were then washed under as described previously, using primers containing the specific mutations. The mutants thus generated were checked by DNA sequencing.
stringent conditions (at 65°C in 2ϫ SSC and 50% formamide) and treated with RNase to remove unhybridized and non-specifically bound The plasmids used in transient transfection experiments have been previously described and were as follows: Tg-CAT and Tg11.5-CAT probe. Autoradiography was performed with a Kodak NT/B2 emulsion. Exposure times were 5-12 days. After development, sections were (Sinclair et al., 1990) , TPO-LUC and TPOZM-LUC (Francis-Lang et al., 1992) , C5E1b-CAT (De Felice et al., 1995) , CMV·TTF-1 (De Felice stained with 0.02% toluidine blue and mounted in De Pex (Serva). Sections were examined and photographed using a Zeiss SV11 microet al., 1995), CMV-Pax-8 (Zannini et al., 1992) .
scope with both dark and bright field illumination.
In vitro transcription and translation
For in vitro transcription, plasmids IVT 1, IVT 2, IVT 3 and IVT 4, containing the wild-type or mutagenized TTF-2 coding region subcloned
